Subscribe

Personalizing Cancer Treatment Based on a Unique Genetic Profile

VBCC - Media Library - Personalized Medicine
Gary Palmer, MD

I think in many ways research is ahead of where the clinician and the patients are, at this point. A large part of what we need to do at Foundation Medicine is educate the physician, and the patients, that a test like ours is available, today, to give them a full information about their DNA, and what drives the cancer.

Most oncologists think this is something that's that’s going to happen down the road, but the research has gotten to the point, now, where a test like ours is available, today. In many ways, the research is ahead of where the clinician and the patients are.

We still have a long ways to go. ; For for instance, trying to find out how genes and alterations interact with each other to drive cancer, rather than just finding them individually.

At Foundation Medicine, we're we’re leading that field by closing what we call the clinical genomic loop, coordinating clinical information along with the alterations that we find, so we really can get a complete picture of how the DNA changes are affecting the cancer.

Related Items
ESR1 Mutations Predict Worse Survival in ER-Positive Advanced Breast Cancer
Phoebe Starr
VBCC - June 2016, Vol 7, No 5 published on June 17, 2016 in Personalized Medicine
Mutation Testing Encouraged for All Patients with Ovarian Cancer
Charles Bankhead
VBCC - June 2016, Vol 7, No 5 published on June 17, 2016 in Personalized Medicine
Genomic Instability Score Predicts Survival in Patients with Ovarian Cancer
Charles Bankhead
VBCC - May 2016, Vol 7, No 4 published on June 3, 2016 in Personalized Medicine
How Do We Measure Quality in the Age of Precision Medicine? Stakeholder Perspectives
Meg Barbor, MPH
VBCC - May 2016, Vol 7, No 4 published on June 3, 2016 in Personalized Medicine
Biomarker for Uveal Melanoma Has Immediate Clinical Impact
Phoebe Starr
VBCC - April 2016, Vol 7, No 3 published on April 21, 2016 in Personalized Medicine
Genomics May Explain Poor Survival of African Americans with Kidney Cancer
Phoebe Starr
VBCC - April 2016, Vol 7, No 3 published on April 21, 2016 in Personalized Medicine
Biomarker Panel May Aid Early Detection of Colorectal Cancer
Charles Bankhead
VBCC - March 2016, Vol 7, No 2 published on March 21, 2016 in Personalized Medicine
Liquid Biopsy Characterizing Circulating Tumor Cells Can Aid Treatment Selection in Prostate Cancer
Phoebe Starr
VBCC - March 2016, Vol 7, No 2 published on March 21, 2016 in Personalized Medicine
Genomic Test Supports Treatment Decisions in Prostate Cancer
Phoebe Starr
VBCC - December 2015, Vol 6, No 11 published on December 16, 2015 in Personalized Medicine
Urine Biopsies Detect Early Mutations in Patients with Advanced Cancers
Wayne Kuznar
VBCC - December 2015, Vol 6, No 11 published on December 16, 2015 in Personalized Medicine
Last modified: September 24, 2015
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology